TOUYUN BIOTECH (01332) announced its interim performance, with a profit attributed to shareholders of approximately HKD 198 million, representing a year-on-year increase of about 16.6 times.

20:57 28/08/2026

Touyun Biotechnology (01332) announced its interim results for 2026, with a gross profit of HKD 9.116 million, a year-on-year decrease of 32.71%; the profit attributable to shareholders was approximately HKD 198 million, a year-on-year increase of approximately 16.6 times; earnings per share were HKD 0.0705.

TOUYUN BIOTECH (01332) announced its mid-year results for 2026, reporting a gross profit of HK$9.116 million, a year-on-year decrease of 32.71%; the profit attributable to the owners of the company was approximately HK$198 million, a year-on-year increase of about 16.6 times; earnings per share were HK$0.0705. The announcement stated that the profit growth was mainly driven by an increase in fair value gains from financial assets measured at fair value through profit or loss.

JIA YAO HLDGS (01626) released its interim results, with a shareholders' profit of 5.996 million yuan, reversing losses from the same period last year.

ANCHORSTONE (01592) released its interim results, reporting a loss attributable to shareholders of HK$3.387 million, a decrease of 61.18% year-on-year.

JIUMAOJIU (09922) announced its interim results, with profit attributable to equity shareholders reaching 75.804 million yuan, a year-on-year increase of 24.9%.

JIA YAO HLDGS (01626) released its interim results, with a shareholders' profit of 5.996 million yuan, reversing losses from the same period last year.

ANCHORSTONE (01592) released its interim results, reporting a loss attributable to shareholders of HK$3.387 million, a decrease of 61.18% year-on-year.

JIUMAOJIU (09922) announced its interim results, with profit attributable to equity shareholders reaching 75.804 million yuan, a year-on-year increase of 24.9%.